NDC product
RevitaDERM Wound Care
NDC 63347-120 · Blaine Labs Inc.
Key facts
| Product NDC | 63347-120 |
|---|---|
| Proprietary name | RevitaDERM Wound Care |
| Nonproprietary name | BENZALKONIUM CHLORIDE |
| Substances | BENZALKONIUM CHLORIDE |
| Dosage form | GEL |
| Route | TOPICAL |
| Labeler | Blaine Labs Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M003 |
| Marketing start | May 24, 2012 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: